Abiomed (NSDQ:ABMD) shares are up 10% in morning trading today after the company posted Street-beating Q1 results and announced the acquisition of Breethe and its potential coronavirus-fighting tech. The Danvers, Mass.-based maker of circulatory support devices — including Impella heart pumps — posted profits of $31.8 million, or 70¢ per share, on sales of $206.7 million […]
breethe
Artificial lung dev Breethe raises $3m
Artificial lung developer Breethe raised approximately $3 million in an equity financing round, according to an SEC filing posted late last month. Funds raised during the round will cover the sales and issuance of Series Seed-4 preferred stock and the underlying common stock convertible from it, according to the filing. The Baltimore-based company is developing the […]